These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19926478)

  • 1. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in targeting HIV-1 entry.
    Ryser HJ; Flückiger R
    Drug Discov Today; 2005 Aug; 10(16):1085-94. PubMed ID: 16182193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
    Meanwell NA; Wallace OB; Wang H; Deshpande M; Pearce BC; Trehan A; Yeung KS; Qiu Z; Wright JJ; Robinson BA; Gong YF; Wang HG; Spicer TP; Blair WS; Shi PY; Lin PF
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5136-9. PubMed ID: 19632112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.
    Connell BJ; Baleux F; Coic YM; Clayette P; Bonnaffé D; Lortat-Jacob H
    Chem Biol; 2012 Jan; 19(1):131-9. PubMed ID: 22284360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
    Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inefficient formation of a complex among CXCR4, CD4 and gp120 in U937 clones resistant to X4 gp120-gp41-mediated fusion.
    Xiao X; Norwood D; Feng YR; Moriuchi M; Jones-Trower A; Stantchev TS; Moriuchi H; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):139-46. PubMed ID: 10816382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.
    Mondor I; Moulard M; Ugolini S; Klasse PJ; Hoxie J; Amara A; Delaunay T; Wyatt R; Sodroski J; Sattentau QJ
    Virology; 1998 Sep; 248(2):394-405. PubMed ID: 9721247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4.
    Ugolini S; Moulard M; Mondor I; Barois N; Demandolx D; Hoxie J; Brelot A; Alizon M; Davoust J; Sattentau QJ
    J Immunol; 1997 Sep; 159(6):3000-8. PubMed ID: 9300725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of soluble recombinant HIV envelope glycoprotein, rgp120, induces conformational changes in the cellular membrane-anchored CD4 molecule.
    Yachou A; Sékaly RP
    Biochem Biophys Res Commun; 1999 Nov; 265(2):428-33. PubMed ID: 10558884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD; Adam FM; Calo F; Fenwick DR; Fok-Seang J; Gardner I; Hay DA; Perros M; Rawal J; Middleton DS; Parkinson T; Pickford C; Platts M; Randall A; Stephenson PT; Vuong H; Williams DH
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5250-5. PubMed ID: 19632839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.